An estimated 20 million people have some form of age-related macular degeneration; Hadley Vision Resources aims to reach one million of them by 2030. President and CEO Johnjoe Farragher discusses help ...

The treatment of diabetic macular oedema (DMO) likely involves a series of treatment ... as a series of treatment ‘episodes’ separated by ‘gaps’ during which the eye is observed without treatment ...

Aim To compare the effect of combined low-dose transpupillary thermotherapy (TTT) and intravitreal ranibizumab with sham TTT and intravitreal ranibizumab in patients with neovascular age-related ...

Background Neovascular age-related macular degeneration (AMD) is a progressive and chronic disease of the eye, and a leading cause of severe blindness in elderly populations. The disease is ...